7.63
price down icon1.55%   -0.12
pre-market  Pre-market:  7.76   0.13   +1.70%
loading
Ginkgo Bioworks Holdings Inc stock is traded at $7.63, with a volume of 667.61K. It is down -1.55% in the last 24 hours and down -8.40% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
See More
Previous Close:
$7.75
Open:
$7.72
24h Volume:
667.61K
Relative Volume:
0.48
Market Cap:
$424.04M
Revenue:
$251.46M
Net Income/Loss:
$-892.87M
P/E Ratio:
-10.75
EPS:
-0.71
Net Cash Flow:
$-336.30M
1W Performance:
-7.74%
1M Performance:
-8.40%
6M Performance:
-80.03%
1Y Performance:
-88.37%
1-Day Range:
Value
$7.43
$7.89
1-Week Range:
Value
$7.43
$8.39
52-Week Range:
Value
$5.26
$75.20

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name
Name
Ginkgo Bioworks Holdings Inc
Name
Phone
(877) 442-5362
Name
Address
27 DRYDOCK AVENUE, BOSTON
Name
Employee
1,218
Name
Twitter
Name
Next Earnings Date
2024-08-08
Name
Latest SEC Filings
Name
DNA's Discussions on Twitter

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date Action Analyst Rating Change
May-15-24 Downgrade BTIG Research Neutral → Sell
May-10-24 Downgrade William Blair Mkt Perform → Underperform
Nov-14-23 Downgrade Raymond James Outperform → Mkt Perform
Nov-09-23 Downgrade BTIG Research Buy → Neutral
Jun-02-23 Downgrade Goldman Neutral → Sell
May-11-23 Downgrade William Blair Outperform → Mkt Perform
Nov-29-22 Initiated Berenberg Buy
Oct-04-22 Initiated Morgan Stanley Equal-Weight
May-18-22 Downgrade BofA Securities Neutral → Underperform
Mar-02-22 Resumed Cowen Outperform
Feb-23-22 Initiated Goldman Neutral
Feb-01-22 Initiated BofA Securities Neutral
Jan-28-22 Initiated BofA Securities Buy
Jan-07-22 Initiated BTIG Research Buy
Nov-29-21 Initiated Jefferies Buy
Oct-13-21 Initiated Raymond James Outperform
Oct-12-21 Initiated William Blair Outperform
Sep-20-21 Initiated HSBC Securities Buy
View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

pulisher
07:01 AM

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - Marketscreener.com

07:01 AM
pulisher
02:29 AM

Vanguard Group Inc's Strategic Reduction in Ginkgo Bioworks Holdings Inc - GuruFocus.com

02:29 AM
pulisher
Nov 04, 2024

Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - MSN

Nov 04, 2024
pulisher
Nov 03, 2024

With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors - Yahoo Finance

Nov 03, 2024
pulisher
Oct 31, 2024

Ginkgo Bioworks (DNA): A Leader in Cell Programming and Genetic Diagnostics - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey

Oct 30, 2024
pulisher
Oct 30, 2024

Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN

Oct 30, 2024
pulisher
Oct 28, 2024

Forbes J M & Co. LLP Invests $1.02 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 28, 2024
pulisher
Oct 27, 2024

PFG Investments LLC Invests $1.54 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 27, 2024
pulisher
Oct 23, 2024

Major Boston biotech company begins layoffs this week - MSN

Oct 23, 2024
pulisher
Oct 22, 2024

Ginkgo Bioworks (NYSE:DNA) Shares Up 5%Here's What Happened - MarketBeat

Oct 22, 2024
pulisher
Oct 19, 2024

Equitec Proprietary Markets LLC Has $99,000 Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 19, 2024
pulisher
Oct 15, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Growth in Short Interest - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Ginkgo Bioworks (NYSE:DNA) Trading 5.9% HigherStill a Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Exchange Traded Concepts LLC Has $2.99 Million Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? - MSN

Oct 14, 2024
pulisher
Oct 14, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Squarepoint Ops LLC - MarketBeat

Oct 14, 2024
pulisher
Oct 13, 2024

Algert Global LLC Takes $36,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 13, 2024
pulisher
Oct 12, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives $4.16 Consensus Target Price from Analysts - MarketBeat

Oct 12, 2024
pulisher
Oct 09, 2024

Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada

Oct 09, 2024
pulisher
Oct 08, 2024

Ginkgo Bioworks executive sells over $10k in company stock By Investing.com - Investing.com Australia

Oct 08, 2024
pulisher
Oct 08, 2024

Ginkgo Bioworks exec sells over $2500 in stock By Investing.com - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

Ginkgo Bioworks executive sells over $10k in company stock - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Ginkgo Bioworks exec sells over $2500 in stock - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Transforming Healthcare From The Inside Out, Nanorobots Are Revolutionizing Treatment With Precision At The Nanoscale: A Report by TNR, The Niche Research - GlobeNewswire Inc.

Oct 08, 2024
pulisher
Oct 08, 2024

Green Alpha Advisors LLC Decreases Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Mackenzie Financial Corp Takes Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 07, 2024
pulisher
Oct 07, 2024

Lesaffre strengthens its Research, Development & Innovation (RD&I) with the acquisition of Altar, a company owned by Ginkgo Bioworks - Yahoo Finance

Oct 07, 2024
pulisher
Oct 07, 2024

Where are the Opportunities in (DNA) - Stock Traders Daily

Oct 07, 2024
pulisher
Oct 04, 2024

Revenues Tell The Story For Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) As Its Stock Soars 33% - Simply Wall St

Oct 04, 2024
pulisher
Oct 03, 2024

Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

Renaissance Technologies LLC Makes New $2.13 Million Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) - MSN

Oct 03, 2024
pulisher
Oct 02, 2024

Nanobots in Healthcare Research Report 2024: A $7.1 Billion Market in 2023Global Forecast to 2030 - GlobeNewswire Inc.

Oct 02, 2024
pulisher
Oct 01, 2024

Rhumbline Advisers Sells 1,331,930 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Wellington Wealth Strategies LLC. Makes New Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Sep 30, 2024
pulisher
Sep 28, 2024

Benjamin F. Edwards & Company Inc. Raises Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World

Sep 28, 2024
pulisher
Sep 28, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Stock Position Lifted by Benjamin F. Edwards & Company Inc. - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN

Sep 27, 2024
pulisher
Sep 27, 2024

933,898 Shares in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Purchased by XTX Topco Ltd - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

(DNA) Trading Advice - Stock Traders Daily

Sep 26, 2024
pulisher
Sep 24, 2024

Novus, Ginkgo Bioworks partner to develop new feed additives - FeedStrategy.com

Sep 24, 2024
pulisher
Sep 24, 2024

NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture - PR Newswire

Sep 24, 2024
pulisher
Sep 21, 2024

What's Going On With Ginkgo Bioworks Stock This Week? - MSN

Sep 21, 2024
pulisher
Sep 20, 2024

Ginkgo Bioworks (NYSE:DNA) PT Raised to $10.00 at TD Cowen - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Ginkgo Bioworks (NYSE:DNA) Shares Down 6.4% - MarketBeat

Sep 20, 2024

Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$19.96
price up icon 5.11%
$75.75
price down icon 0.50%
$376.80
price up icon 0.74%
$53.54
price down icon 2.00%
$207.25
price up icon 1.49%
$108.97
price down icon 2.25%
Cap:     |  Volume (24h):